Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA

Tullio Esposito

A Novel Combination of Antibody-Targeted Radiotherapy and Immunotherapy for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Pancreas

Nathaniel Rothman

Studies in the Janus Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Pathology

Investigator from Spanish National Centre for Cardiovascular Research

Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment

Pancreas

Ann M Killary

Biomarkers for the Early Detection of Pancreatic Cancer

Pancreas

Pathology

Samuel I Gunderson

Preclinical Validation of U1 Adaptors for Suppression of KRAS in Pancreatic Cancer

Pancreas

Kelvin P Lee

Roswell Park Cancer Center CimaVax Partnership with the Center for Molecular Immunology in Havana, Cuba

Trachea, bronchus and lung Prostate Pancreas Colorectum Breast All cancers but non-melanoma skin cancer

Anthony G Letai

Investigation of therapeutic modulators of apoptotic priming in pancreatic cancer

Pancreas

Pathology

Eric Collisson

Crucial Microenvironmental Cofactors for Pancreatic Cancer Pathogenesis

Pancreas

Pathology

Keping Xie

Functional Validation of Pancreatic Cancer Progression Biomarker

Pancreas

Pathology